Dou Lei, Zheng Yu, Feng Junchao, Huang Zhezhou, Qin Fei, Gao Mingyue, Li Shunping
Department of Social Medicine and Health Management, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People's Republic of China.
NHC Key Laboratory of Health Economics and Policy Research (Shandong University), Jinan, Shandong, People's Republic of China.
Int J Chron Obstruct Pulmon Dis. 2025 Aug 27;20:2993-3004. doi: 10.2147/COPD.S524028. eCollection 2025.
Chronic obstructive pulmonary disease (COPD) is a leading cause of death in China. However, few national surveys have comprehensively evaluated the health and economic outcomes among COPD patients in China. The objective of this study was to examine and compare the humanistic and economic burden of COPD patients with a control group.
Data from the 2020 National Health and Wellness Survey (NHWS) in China (N=20051), a nationally representative survey targeting urban adults, was used in this study. The propensity score matching (PSM) method was employed to match respondents who reported being diagnosed with COPD by a physician with those who did not have COPD. Differences between COPD patients and matched controls were assessed in terms of quality of life (using EQ-5D-5L and SF-12v2), work productivity loss, healthcare resource utilization over the past 6 months, and estimated annual indirect costs.
COPD patients exhibited significantly worse outcomes compared to non-COPD respondents. The mean scores for MCS, PCS, and health state utility (HSU) were substantially lower in COPD patients than in the control group (47.69 vs 49.49, 47.27 vs 51.71, and 0.90 vs 0.94, respectively; all P <0.01). Moreover, the score difference between COPD patients and the control group reached minimal clinically important difference (MCID) for both PCS and HSU. Compared to the non-COPD population, COPD patients reported higher rates of absenteeism (6.88% vs 3.74%, P<0.01), presenteeism (28.02% vs 21.43%, P<0.01), work productivity loss (31.31% vs 23.57%, P<0.01) and activity impairment (27.15% vs 19.53%, P<0.01), resulting in greater indirect cost. The number of hospitalizations was significantly higher among COPD patients than the non-COPD population (2.11 vs 1.96, P<0.01), while the number of outpatient visits was similar to that of the control group.
These findings highlight the pervasive impact of COPD on health outcomes. The results highlight the substantial burden of COPD compared with the non-COPD population, suggesting that increased attention and targeted interventions are warranted to address the significant health and economic challenges posed by this disease.
慢性阻塞性肺疾病(COPD)是中国主要的死亡原因之一。然而,很少有全国性调查全面评估中国COPD患者的健康和经济状况。本研究的目的是检查和比较COPD患者与对照组的人文和经济负担。
本研究使用了2020年中国国家健康与幸福调查(NHWS)的数据(N = 20051),该调查是一项针对城市成年人的全国代表性调查。采用倾向得分匹配(PSM)方法,将报告被医生诊断为COPD的受访者与未患COPD的受访者进行匹配。从生活质量(使用EQ - 5D - 5L和SF - 12v2)、工作生产力损失、过去6个月的医疗资源利用情况以及估计的年度间接成本等方面评估COPD患者与匹配对照组之间的差异。
与非COPD受访者相比,COPD患者的结果明显更差。COPD患者的MCS、PCS和健康状态效用(HSU)平均得分显著低于对照组(分别为47.69对49.49、47.27对51.71和0.90对0.94;所有P <0.01)。此外,COPD患者与对照组之间的得分差异在PCS和HSU方面均达到最小临床重要差异(MCID)。与非COPD人群相比,COPD患者报告的旷工率(6.88%对3.74%,P<0.01)、出勤主义(28.02%对21.43%,P<0.01)、工作生产力损失(31.31%对23.57%,P<0.01)和活动障碍(27.15%对19.53%,P<0.01)更高,导致间接成本更大。COPD患者的住院次数显著高于非COPD人群(2.11对1.96,P<0.01),而出诊次数与对照组相似。
这些发现突出了COPD对健康结果的广泛影响。结果强调了与非COPD人群相比,COPD的巨大负担,表明需要更多关注和有针对性的干预措施来应对这种疾病带来的重大健康和经济挑战。